Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Felosan
2. Nicotinylhydroxymethylamide
1. 3569-99-1
2. Nicoform
3. N-hydroxymethylnicotinamide
4. Nikomethamide
5. Bilamid
6. Nicodine
7. Nicodin
8. Nikodin
9. Coloton
10. Nikoform
11. Choligen
12. N-(hydroxymethyl)pyridine-3-carboxamide
13. Hydroxymethylnicotinamide
14. Nicotinamide, N-(hydroxymethyl)-
15. 3-pyridinecarboxylic Acid Hydroxymethylamide
16. N-(hydroxymethyl)-3-pyridinecarboxamide
17. 3-pyridinecarboxamide, N-(hydroxymethyl)-
18. N-(hydroxymethyl)-nicotinamide
19. Bilizorin
20. Bilocid
21. Cholamid
22. N-hydroxymethyl-nicotinamide
23. N-(hytroxymethy)micotinamide
24. 1n1ygm997e
25. Isochol
26. Mfcd00010437
27. Nicometamide
28. Bidbilan
29. Savatin
30. Nifoform
31. Cholamide (pyridine Deriv.)
32. Nicotinsaeurehydroxymethylamid
33. Nicotinylmethylamide
34. Einecs 222-668-4
35. C 1094
36. Brn 0128633
37. Unii-1n1ygm997e
38. Cholamid (tn)
39. Nikoform (tn)
40. Spectrum_000376
41. Specplus_000641
42. Nicotinylmethylamide,(s)
43. Spectrum2_001197
44. Spectrum3_001014
45. Spectrum4_001142
46. Spectrum5_001885
47. Oprea1_521547
48. Oprea1_687785
49. Bspbio_002767
50. Kbiogr_001683
51. Kbioss_000856
52. Mls002695904
53. Chembl92024
54. Divk1c_006737
55. Schembl352358
56. Spectrum2300137
57. Spbio_001273
58. Jrfkioflcxkvot-uhfffaoysa-
59. Kbio1_001681
60. Kbio2_000856
61. Kbio2_003424
62. Kbio2_005992
63. Kbio3_001987
64. Dtxsid20189205
65. Chebi:134775
66. Zinc409246
67. Albb-023192
68. N-(hydroxymethyl)nicotinamide, 98%
69. Ccg-40316
70. S5390
71. Akos000121436
72. Ac-6974
73. Ncgc00095786-01
74. Ncgc00095786-02
75. As-59855
76. Hydroxymethylnicotinamide [who-dd]
77. Smr001562101
78. Sy051839
79. N-(hydroxymethyl)nicotinamide [mi]
80. Hy-116993
81. A6230
82. Cs-0066962
83. Ft-0629289
84. H1001
85. D08051
86. D90986
87. W-106656
88. Q27252632
| Molecular Weight | 152.15 g/mol |
|---|---|
| Molecular Formula | C7H8N2O2 |
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 152.058577502 g/mol |
| Monoisotopic Mass | 152.058577502 g/mol |
| Topological Polar Surface Area | 62.2 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 138 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A N-(Hydroxymethyl)Nicotinamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-(Hydroxymethyl)Nicotinamide, including repackagers and relabelers. The FDA regulates N-(Hydroxymethyl)Nicotinamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-(Hydroxymethyl)Nicotinamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-(Hydroxymethyl)Nicotinamide supplier is an individual or a company that provides N-(Hydroxymethyl)Nicotinamide active pharmaceutical ingredient (API) or N-(Hydroxymethyl)Nicotinamide finished formulations upon request. The N-(Hydroxymethyl)Nicotinamide suppliers may include N-(Hydroxymethyl)Nicotinamide API manufacturers, exporters, distributors and traders.
N-(Hydroxymethyl)Nicotinamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-(Hydroxymethyl)Nicotinamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-(Hydroxymethyl)Nicotinamide GMP manufacturer or N-(Hydroxymethyl)Nicotinamide GMP API supplier for your needs.
A N-(Hydroxymethyl)Nicotinamide CoA (Certificate of Analysis) is a formal document that attests to N-(Hydroxymethyl)Nicotinamide's compliance with N-(Hydroxymethyl)Nicotinamide specifications and serves as a tool for batch-level quality control.
N-(Hydroxymethyl)Nicotinamide CoA mostly includes findings from lab analyses of a specific batch. For each N-(Hydroxymethyl)Nicotinamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-(Hydroxymethyl)Nicotinamide may be tested according to a variety of international standards, such as European Pharmacopoeia (N-(Hydroxymethyl)Nicotinamide EP), N-(Hydroxymethyl)Nicotinamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-(Hydroxymethyl)Nicotinamide USP).
LOOKING FOR A SUPPLIER?
